Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Nivocasan

Known as: (5R)-N-((2S,3S)-2-(Fluoromethyl)-2-hydroxy-5-oxo-tetrahydrofuran-3-yl)-3-(isoquinolin- 1-yl)-5-(1-methylethyl)-4,5-dihydroisoxazole-5-carboxamide, 5-isoxazolecarboxamide, N-((2S,3S)-2-(fluoromethyl)tetrahydro-2-hydroxy-5-oxo-3-furanyl)-4,5-dihydro-3-(1-isoquinolinyl)-5-(1-methylethyl)-, (5R)- 
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

GS-9450

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Auranofin Inhibits RANKL-Induced Osteoclastogenesis by Suppressing Inhibitors of κB Kinase and Inflammasome-Mediated Interleukin-1β Secretion
Osteoporosis is a degenerative metabolic disease caused by an imbalance between osteogenesis and osteoclastogenesis. Increased… 
  • figure 1
  • figure 2
  • figure 3
  • figure 3
  • figure 4
2013
2013
Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats
We sought to determine the hepatic fibrosis-reversal effects upon simultaneous administration of lithospermate B (LAB), an anti… 
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE